US Patent Issued to The United States of America as represented by the Secretary, Department of Health and Human Services on March 3 for "Monoclonal antibodies that bind EGFRvIII and their use" (Maryland Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,532, issued on March 3, was assigned to The United States of America as represented by the Secretary, Department of Health and Human Services (Bethesda, Miss.).

"Monoclonal antibodies that bind EGFRvIII and their use" was invented by David Joseph FitzGerald (Rockville, Md.), Eric Chun Hei Ho (Rockville, Md.), Antonella Antignani (Potomac, Md.) and Robert Joseph Sarnovsky (Phoenix, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are monoclonal antibodies and antigen binding fragments that specifically bind epidermal growth factor receptor (EGFR) variant (v) III, conjugates thereof, and chimeric antigen receptors. Nucleic acid molecules e...